132 related articles for article (PubMed ID: 35339100)
1. Development of oxoisoaporphine derivatives with topoisomerase I inhibition and reversal of multidrug resistance in breast cancer MCF-7/ADR cells.
Zhong H; Zhao M; Wu C; Zhang J; Chen L; Sun J
Eur J Med Chem; 2022 May; 235():114300. PubMed ID: 35339100
[TBL] [Abstract][Full Text] [Related]
2. Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin.
Abdalla AN; Di Stefano M; Poli G; Tuccinardi T; Bader A; Vassallo A; Abdallah ME; El-Readi MZ; Refaat B; Algarni AS; Ahmad R; Alkahtani HM; Abdel-Aziz AA; El-Azab AS; Alqathama A
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011321
[TBL] [Abstract][Full Text] [Related]
3. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
4. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
5. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel highly potent and low-toxic jatrophane derivative enhancing the P-glycoprotein-mediated doxorubicin sensitivity of MCF-7/ADR cells.
Maimaitijiang A; Wang B; Yang H; Tang D; Liu Y; Aisa HA
Eur J Med Chem; 2022 Dec; 244():114822. PubMed ID: 36242992
[TBL] [Abstract][Full Text] [Related]
7. The reversal effects of 3-bromopyruvate on multidrug resistance in vitro and in vivo derived from human breast MCF-7/ADR cells.
Wu L; Xu J; Yuan W; Wu B; Wang H; Liu G; Wang X; Du J; Cai S
PLoS One; 2014; 9(11):e112132. PubMed ID: 25372840
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 2,5-disubstituted furan derivatives featuring a benzamide motif for overcoming P-glycoprotein mediated multidrug resistance in MCF-7/ADR cell.
Yang Z; Cai Y; Mao S; Wu Q; Zhu M; Cao X; Wei B; Tian JM; Bao X; Ye X; Chen J; Wang S; Yu Y; Zhang H; Sun X; Cui ZN; Li YS; Wang H
Eur J Med Chem; 2023 Sep; 257():115462. PubMed ID: 37229830
[TBL] [Abstract][Full Text] [Related]
9. Aconitine linoleate, a natural lipo-diterpenoid alkaloid, stimulates anti-proliferative activity reversing doxorubicin resistance in MCF-7/ADR breast cancer cells as a selective topoisomerase IIα inhibitor.
Luan S; Gao Y; Liang X; Zhang L; Wu Q; Hu Y; Yin L; He C; Liu S
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jan; 395(1):65-76. PubMed ID: 34727218
[TBL] [Abstract][Full Text] [Related]
10. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer.
Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y
Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704
[TBL] [Abstract][Full Text] [Related]
11. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z
Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell.
Li YS; Yang X; Zhao DS; Cai Y; Huang Z; Wu R; Wang SJ; Liu GJ; Wang J; Bao XZ; Ye XY; Wei B; Cui ZN; Wang H
Eur J Med Chem; 2021 Apr; 216():113336. PubMed ID: 33725657
[TBL] [Abstract][Full Text] [Related]
13. Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway.
Yang L; Zhang C; Chen J; Zhang S; Pan G; Xin Y; Lin L; You Z
Pharm Biol; 2020 Dec; 58(1):276-285. PubMed ID: 32251615
[No Abstract] [Full Text] [Related]
14. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
Li H; Krstin S; Wink M
Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
[TBL] [Abstract][Full Text] [Related]
15. Acerinol, a cyclolanstane triterpenoid from Cimicifuga acerina, reverses ABCB1-mediated multidrug resistance in HepG2/ADM and MCF-7/ADR cells.
Liu DL; Li YJ; Yao N; Xu J; Chen ZS; Yiu A; Zhang CX; Ye WC; Zhang DM
Eur J Pharmacol; 2014 Jun; 733():34-44. PubMed ID: 24704556
[TBL] [Abstract][Full Text] [Related]
16. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
[TBL] [Abstract][Full Text] [Related]
17. Discovery of benzochromene derivatives first example with dual cytotoxic activity against the resistant cancer cell MCF-7/ADR and inhibitory effect of the
Al-Harbi LM; Al-Harbi EA; Okasha RM; El-Eisawy RA; El-Nassag MAA; Mohamed HM; Fouda AM; Elhenawy AA; Mora A; El-Agrody AM; El-Mawgoud HKA
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2155814. PubMed ID: 36662632
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 9-Hydroxy-1
Albalawi FF; El-Nassag MAA; El-Eisawy RA; Mohamed MBI; Fouda AM; Afifi TH; Elhenawy AA; Mora A; El-Agrody AM; El-Mawgoud HKA
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613493
[No Abstract] [Full Text] [Related]
19. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
[TBL] [Abstract][Full Text] [Related]
20. Gamma-tocotrienol reverses multidrug resistance of breast cancer cells with a mechanism distinct from that of atorvastatin.
Ding Y; Peng Y; Deng L; Fan J; Huang B
J Steroid Biochem Mol Biol; 2017 Mar; 167():67-77. PubMed ID: 27864002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
